Waystar (NASDAQ:WAY) Given New $35.00 Price Target at Truist Financial

Waystar (NASDAQ:WAY – Get Free Report) had its price target raised by Truist Financial from $33.00 to $35.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial‘s price objective would indicate a potential upside of 21.55% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. Citigroup reissued a “buy” rating on shares of Waystar in a research note on Monday, July 20th. TD Cowen cut their price target on shares of Waystar from $42.00 to $39.00 and set a “buy” rating on the stock in a research note on Tuesday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $39.00 price objective on shares of Waystar in a report on Friday, July 31st. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Waystar in a research note on Tuesday, September 15th. Finally, KeyCorp increased their target price on Waystar from $30.00 to $35.00 and gave the stock an “overweight” rating in a report on Friday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $35.23.

Get Our Latest Analysis on Waystar

Waystar Price Performance

Shares of NASDAQ WAY traded up $1.13 during midday trading on Wednesday, reaching $28.79. 1,286,225 shares of the company traded hands, compared to its average volume of 2,540,703. Waystar has a 12 month low of $17.26 and a 12 month high of $37.51. The firm has a market cap of $5.52 billion, a PE ratio of 41.78, a PEG ratio of 1.10 and a beta of 0.11. The stock’s 50-day simple moving average is $26.27 and its 200-day simple moving average is $23.96. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.85 and a current ratio of 1.85.

Waystar (NASDAQ:WAY – Get Free Report) last released its quarterly earnings results on Monday, November 2nd. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.41 by $0.03. Waystar had a net margin of 10.70% and a return on equity of 6.95%. The firm had revenue of $325.62 million for the quarter, compared to analyst estimates of $323.43 million. During the same period in the previous year, the business earned $0.37 earnings per share. The company’s revenue for the quarter was up 21.2% compared to the same quarter last year. As a group, equities analysts anticipate that Waystar will post 1.47 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Matthew Hawkins sold 82,500 shares of the business’s stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $26.23, for a total transaction of $2,163,975.00. Following the transaction, the chief executive officer directly owned 1,804,794 shares in the company, valued at $47,339,746.62. The trade was a 4.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 247,500 shares of company stock valued at $6,370,499 in the last ninety days. Company insiders own 3.50% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in WAY. Canada Pension Plan Investment Board bought a new position in Waystar in the 2nd quarter valued at about $390,593,000. BlackRock Inc. bought a new position in shares of Waystar during the second quarter worth approximately $357,950,000. Advent International L.P. acquired a new stake in Waystar during the 2nd quarter worth approximately $227,060,000. Jupiter Topco LLC bought a new stake in Waystar in the 2nd quarter valued at $58,960,000. Finally, Bank of America Corp DE bought a new stake in Waystar in the 2nd quarter valued at $53,031,000.

Trending Headlines about Waystar

Here are the key news stories impacting Waystar this week:

  • Positive Sentiment: Waystar reported Q3 revenue of $325.6 million, up 21% year over year, and adjusted EPS of $0.44, topping estimates of $323.4 million and $0.41, respectively. Adjusted EBITDA margin was 43%. Waystar Reports Third Quarter 2026 Results
  • Positive Sentiment: Deutsche Bank raised its price target to $42 from $39 and maintained a Buy rating, signaling continued analyst confidence. Deutsche Bank Raises Price Target on Waystar
  • Positive Sentiment: RBC Capital Markets cited solid leading indicators and expects them to convert into revenue in 2027, supporting the longer-term growth outlook. RBC Capital Markets on Waystar’s Leading Indicators
  • Positive Sentiment: Canaccord Genuity raised its price target to $34 from $33 and kept its Buy rating. Canaccord Genuity recommendations
  • Neutral Sentiment: Waystar’s 2026 EPS guidance of $1.63–$1.71 is in line with or above the $1.63 consensus, and the company raised its adjusted EBITDA outlook to $543–$549 million. However, its $1.277–$1.287 billion revenue forecast is below the roughly $1.3 billion consensus. Waystar updates 2026 outlook
  • Neutral Sentiment: TD Cowen cut its price target to $39 from $42 but retained a Buy rating, making the analyst revisions mixed overall. TD Cowen recommendations

Waystar Company Profile

(Get Free Report)

Waystar Holding Corp. is a healthcare technology company that provides cloud-based software designed to simplify administrative and financial processes across the healthcare industry. Its platform connects healthcare providers, health plans and patients, helping organizations manage revenue cycle operations and improve the flow of information and payments.

The company’s products and services include electronic claims management, eligibility and benefits verification, prior authorization, payment integrity, denial management, patient estimates and payments, billing automation, and healthcare analytics.

Featured Articles

Analyst Recommendations for Waystar (NASDAQ:WAY)

Receive News & Ratings for Waystar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waystar and related companies with MarketBeat.com's FREE daily email newsletter.